Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc
Molecules · 2025
DOI: 10.3390/molecules30153054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Roberta Santarelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Curcumin, Tumor Suppressor Protein p53, Colonic Neoplasms, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, PRIN, ATENEO.
Abstract (Originalsprache)
Curcumin-mediated anti-cancer properties have been correlated with the inhibition of oncogenic molecules such as mutp53 and c-Myc. Their targeting is therapeutically significant, as p53, following point mutations, can acquire oncogenic functions, and c-Myc overexpression, due to translocations, point mutations, protein/protein interactions, or epigenetic modifications, plays a central role in cancer cell proliferation and metabolic reprogramming, particularly in colorectal cancer. In a previous study, we showed that curcumin strongly downregulated mutp53 while activating wtp53 and reduced the expression of methyltransferases such as EZH2, G9a, and MLL-1 in colon cancer cells. Based on this background, here we investigated whether the dysregulation of such methyltransferases could correlate with the effect observed on p53. We also explored whether these epigenetic changes could affect c-Myc expression in these cells. By Western blot analysis and RT-qPCR, we found that the downregulation of EZH2; G9a; and, to a lesser extent, KDM1, which was also reduced by curcumin, correlated with the decrease in mutp53 and that the reduction of EZH2 and KDM1 correlated with the activation of wtp53. Regarding c-Myc, we unveiled the occurrence of a positive feedback loop between it and MLL-1, which was inhibited by curcumin, independently of the p53 status. In conclusion, this study provides new insights into the therapeutic potential of curcumin, which involves its properties to act as an epigenetic modulator and target key molecules in colon cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
ORCID-Profile: Roberta Santarelli, Roberta Gonnella, Mara Cirone
Förderung
- Italian Association for Cancer Research
- PRIN
- ATENEO
Zitieren
APA
Santarelli, R., Di Dio, C., Di Crosta, M., Currà, P., Gonnella, R., & Cirone, M. (2025). Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc. Molecules. https://doi.org/10.3390/molecules30153054
Vancouver
Santarelli R, Di Dio C, Di Crosta M, Currà P, Gonnella R, Cirone M. Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc. Molecules. 2025. doi:10.3390/molecules30153054
BibTeX
@article{Santarelli2025,
author = {Santarelli, Roberta and Di Dio, Claudia and Di Crosta, Michele and Currà, Paola and Gonnella, Roberta and Cirone, Mara},
title = {Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30153054}
}
EUVIMED